In all cases (13 cases of LELCC and 15 cases of IHCC), PD-L1 expression in tumor-infiltrating immune cells was higher in the patients with EBV infection (P = 0.004) (Table 5). The gene discussed is CD274; the disease is Epstein-Barr virus infection.